The cultivated meat industry hit a historic milestone
In November 2022, the U.S. Food & Drug Administration (FDA) green-lit UPSIDE Foods’ cultivated chicken, marking the first time a cultivated meat product has completed the agency’s rigorous pre-market safety review. In spring 2023, FDA announced that a second cultivated meat product, GOOD Meat’s cultivated chicken, also received the green light. And in the summer of 2023, the USDA granted final approval, including label approval and a grant of inspection, to both UPSIDE Foods’ and GOOD Meat’s cultivated chicken products.
- There are now 159 dedicated cultivated meat companies across the world, with representation across 32 different countries and every major world region.
- Cultivated meat companies raised $896 million in 2022, bringing all-time investment to $2.8 billion.
- In 2022, a number of new peer-reviewed studies covering cultivated meat production were released, including a techno-economic assessment, a life cycle assessment, and studies covering serum-free media development and antibiotic use.
- A number of governments around the globe have funded public R&D into cultivated meat or granted funds to cultivated meat startups, including Australia, China, the European Union, Israel, India, Japan, New Zealand, Qatar, Singapore, South Korea, Spain, the United Kingdom, and the United States.
State of the Industry Report: Cultivated meat
This report details the commercial landscape, investments, regulatory developments, and scientific progress in the cultivated meat and seafood industry.
Learn about the science of cultivated meat and the challenges that must be addressed for commercial production.
Our annual State of Global Policy Report tracks public investment in alternative proteins and showcases the actions governments took to position themselves as leaders in the field.
The U.S. Food and Drug Administration gave the go-ahead to a cultivated meat product for the first time, prompting questions about this novel production method and the future of meat.…
Countries are sharing updates on the regulatory frameworks that can help scale the alt protein industry around the world